| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-07-2485 |
| P698 | PubMed publication ID | 17975006 |
| P50 | author | Akila Viswanathan | Q55149578 |
| Eva Schernhammer | Q62586412 | ||
| Susan E. Hankinson | Q76570836 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 10618-10622 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Night shift work and the risk of endometrial cancer | |
| P478 | volume | 67 |
| Q37373255 | A role for the clock gene per1 in prostate cancer |
| Q54157077 | Altered Circadian Rhythms and Breast Cancer: From the Human to the Molecular Level |
| Q97527040 | Association Between Night-Shift Work and Cancer Risk: Updated Systematic Review and Meta-Analysis |
| Q28391051 | Associations between rotating night shifts, sleep duration, and telomere length in women |
| Q36162612 | Associations of Short Sleep and Shift Work Status with Hypertension among Black and White Americans |
| Q36960337 | Bmal1 suppresses cancer cell invasion by blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway |
| Q38662592 | Cadmium exposure and endometrial cancer risk: A large midwestern U.S. population-based case-control study |
| Q40039837 | Can yesterday's smoking research inform today's shiftwork research? Epistemological consequences for exposures and doses due to circadian disruption at and off work. |
| Q99550813 | Cancer in the Fourth Dimension: What Is the Impact of Circadian Disruption? |
| Q24704191 | Cancer incidence among police officers in a U.S. northeast region: 1976-2006 |
| Q92445608 | Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma |
| Q41921459 | Circadian Rhythm Disruption Promotes Lung Tumorigenesis |
| Q28396717 | Circadian Rhythm Sleep Disorders |
| Q50045797 | Circadian clock and oral cancer |
| Q38052599 | Circadian clock disruptions and the risk of cancer |
| Q37635574 | Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms |
| Q34222534 | Circadian disruption, Per3, and human cytokine secretion |
| Q34127839 | Circadian gene variants in cancer. |
| Q37766876 | Circadian regulation of cell cycle: Molecular connections between aging and the circadian clock. |
| Q33784815 | Circadian rhythm and its role in malignancy |
| Q37212814 | Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer |
| Q37710946 | Circadian rhythms and cancer |
| Q43204661 | Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women |
| Q26796457 | Circadian systems biology: When time matters |
| Q37328085 | Circulating melatonin and the risk of breast and endometrial cancer in women. |
| Q54959553 | Clinical chronobiology: a timely consideration in critical care medicine. |
| Q48092664 | Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney. |
| Q45998502 | Computing chronodisruption: how to avoid potential chronobiological errors in epidemiological studies of shift work and cancer. |
| Q54570627 | Controlling health hazards to hospital workers. |
| Q38208057 | Cross-talk between the circadian clock and the cell cycle in cancer. |
| Q34692268 | Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer |
| Q53084256 | Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. |
| Q35141105 | Deregulated expression of circadian clock genes in gastric cancer |
| Q48404598 | Deregulated expression of the clock genes in gliomas |
| Q37348377 | Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts |
| Q31054756 | Discovering Biology in Periodic Data through Phase Set Enrichment Analysis (PSEA). |
| Q37396036 | Disruption of clock gene expression in human colorectal liver metastases. |
| Q41565474 | Dysfunction of the circadian transcriptional factor CLOCK in mice resists chemical carcinogen-induced tumorigenesis |
| Q64115450 | Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers |
| Q89881916 | Embedding Mobile Health Technology into the Nurses' Health Study 3 to Study Behavioral Risk Factors for Cancer |
| Q37840257 | Generational influences in academic emergency medicine: structure, function, and culture (Part II). |
| Q36634647 | Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients |
| Q30947207 | High prevalence of breast cancer in light polluted areas in urban and rural regions of South Korea: An ecologic study on the treatment prevalence of female cancers based on National Health Insurance data |
| Q58396534 | How Shift Work and a Destabilized Circadian System may Increase Risk for Development of Cancer and Type 2 Diabetes |
| Q56851258 | IS LIGHT-AT-NIGHT A HEALTH RISK FACTOR OR A HEALTH RISK PREDICTOR? |
| Q47653834 | Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. |
| Q90239278 | Impact of shift work schedules on actigraphy-based measures of sleep in Hispanic workers: results from the Hispanic Community Health Study/Study of Latinos ancillary Sueño study |
| Q33559921 | Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells |
| Q90483971 | Insights About Circadian Clock and Molecular Pathogenesis in Gliomas |
| Q48039578 | LED light between Nobel Prize and cancer risk factor |
| Q43241340 | Light intensity exposure, sleep duration, physical activity, and biomarkers of melatonin among rotating shift nurses |
| Q37324097 | Light-at-night, circadian disruption and breast cancer: assessment of existing evidence |
| Q37665036 | Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. |
| Q38815882 | Longitude Position in a Time Zone and Cancer Risk in the United States. |
| Q37049406 | Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy |
| Q28388678 | Malignant tumors of the female reproductive system |
| Q33397763 | Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials |
| Q21284184 | Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways |
| Q28393796 | Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance |
| Q48259194 | Melatonin production and light exposure of rotating night workers |
| Q35172397 | Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells |
| Q99207689 | Metabolic rivalry: circadian homeostasis and tumorigenesis |
| Q58914961 | Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction |
| Q92000682 | Neuromodulation of the Pineal Gland via Electrical Stimulation of Its Sympathetic Innervation Pathway |
| Q47556670 | Night Shift Work Increases the Risks of Multiple Primary Cancers in Women: A Systematic Review and Meta-analysis of 61 Articles |
| Q92853561 | Night Shift Work-A Risk Factor for Breast Cancer |
| Q28388457 | Night shift work and levels of 6-sulfatoxymelatonin and cortisol in men |
| Q23911251 | Night shift work at specific age ranges and chronic disease risk factors |
| Q46895765 | Night work and mortality: prospective study among Finnish employees over the time span 1984 to 2008. |
| Q38153437 | Night work and the reproductive health of women: an integrated literature review |
| Q37184554 | Nightshift work and risk of ovarian cancer |
| Q28274910 | PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs |
| Q34060495 | Period 2 mutation accelerates ApcMin/+ tumorigenesis |
| Q28388918 | Phase advancing human circadian rhythms with morning bright light, afternoon melatonin, and gradually shifted sleep: can we reduce morning bright-light duration? |
| Q38455270 | Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression |
| Q23917784 | Practical interventions to promote circadian adaptation to permanent night shift work: study 4 |
| Q26739736 | Prevention of fatigue and insomnia in shift workers-a review of non-pharmacological measures |
| Q28385442 | Protecting the melatonin rhythm through circadian healthy light exposure |
| Q37979963 | Role of circadian clocks in the development and therapeutics of cancer |
| Q38063565 | Role of melatonin on electromagnetic radiation-induced oxidative stress and Ca2+ signaling molecular pathways in breast cancer |
| Q77792362 | Rotating night shift work and menopausal age |
| Q34949853 | Rotating night shift work and risk of ovarian cancer. |
| Q34764890 | Rotating night shifts and risk of skin cancer in the nurses' health study |
| Q37268633 | Rotating night-shift work and lung cancer risk among female nurses in the United States |
| Q60938745 | Sex Differences in the Association between Night Shift Work and the Risk of Cancers: A Meta-Analysis of 57 Articles |
| Q23917781 | Shaping the light/dark pattern for circadian adaptation to night shift work |
| Q35777311 | Shift Work and Obesity among Canadian Women: A Cross-Sectional Study Using a Novel Exposure Assessment Tool |
| Q23920017 | Shift work and cancer screening: do females who work alternative shifts undergo recommended cancer screening? |
| Q34196631 | Shift work and cancer: the evidence and the challenge |
| Q28397062 | Shift work: health, performance and safety problems, traditional countermeasures, and innovative management strategies to reduce circadian misalignment |
| Q34490935 | Short duration of sleep increases risk of colorectal adenoma |
| Q31061663 | Sleep and cancer: Synthesis of experimental data and meta-analyses of cancer incidence among some 1,500,000 study individuals in 13 countries |
| Q36661791 | Sleep disturbance and incidence of thyroid cancer in postmenopausal women the Women's Health Initiative |
| Q28391366 | Sleep duration and breast cancer phenotype |
| Q34987717 | Sleep duration and breast cancer risk: a meta-analysis of observational studies |
| Q46972291 | Sleep duration and endometrial cancer risk |
| Q35962713 | Sleep: a health imperative |
| Q38973727 | The Pathophysiologic Role of Disrupted Circadian and Neuroendocrine Rhythms in Breast Carcinogenesis |
| Q36882589 | The Reduction in Circulating Melatonin Level May Contribute to the Pathogenesis of Ovarian Cancer: A Retrospective Study |
| Q34789441 | The association between shift work and hyperuricemia in steelmaking male workers |
| Q28390451 | The circadian clock in cancer development and therapy |
| Q52604677 | The role of polymorphisms in circadian pathway genes in breast tumorigenesis. |
| Q92630401 | Time-Restricted Eating to Prevent and Manage Chronic Metabolic Diseases |
| Q37494101 | Urinary melatonin levels and skin malignancy |
| Q23910078 | Validation of a light questionnaire with real-life photopic illuminance measurements: the Harvard Light Exposure Assessment questionnaire |
| Q35040158 | Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer |
| Q38184659 | Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer |
Search more.